BioAge Labs, Inc. Common Stock (NASDAQ: BIOA) last traded at $9.48, down 2.17% on the session. The quote above updates while this page is open; the figures below are drawn from BioAge Labs, Inc. Common Stock’s own filings and are restated only when a new one is published.
BioAge Labs, Inc. Common Stock trades on NASDAQ under the ticker BIOA. Its market capitalisation is $435.10 million.
Valuation measures for BioAge Labs, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $435.10M |
|---|---|
| Enterprise value | $383.15M |
| Price / sales | 42.02 |
| Price / book | 1.16 |
| Beta | 1.75 |
Trailing-twelve-month figures tagged in BioAge Labs, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.36M |
|---|---|
| Net income (TTM) | -$94.46M |
| EPS (TTM) | -$2.38 |
| Operating margin | -1026.28% |
| Return on equity | -25.20% |
| Cash | $73.96M |
Range and volume for BIOA over the past 52 weeks.
| 52-week high | $25.96 |
|---|---|
| 52-week low | $4.42 |
| Volume | 453.2K |
| Average volume | 843.6K |
| Previous close | $9.69 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.